Trade Summary

3 days ago, Saxena Nishant C, serving as Chief Business Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), purchased 13,500 shares at $7.50 per share, for a total transaction value of $101,218.50. Following this transaction, Saxena Nishant C now holds 75,300 shares of CRBP.

This purchase represents a 21.84% increase in Saxena Nishant C's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 3, 2026 at 5:36 PM ET, 1 day after the trade was made.

Corbus Pharmaceuticals Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.